| BIOMARIN PHAR. DL-,001 | 69,15 / +0,52% |
| 日期/时间 | 19.01. / 10:01 |
| 涨跌。 / 涨跌。(%) | 0,36 / +0,52% |
| Bid | 69,13 / 80 |
| Ask | 69,48 / 80 |
| 打开 | 69,23 |
| 以往收市 | 68,79 |
| 高 | 69,34 |
| 低 | 69,15 |
| 成交量 [EUR] | 0,00 |
| 成交量 [Units] | 0 |
| Price fixings | 4 |
| ISIN | US09061G1013 |
| 符号 | BM8 |
| 交易所 | Düsseldorf |
| 类型 | 股票 |
所有交易
| 交易所 | 最后的 | 成交量 | |
|---|---|---|---|
| Xetra | 69,32 |  |
50 |
| Berlin | 69,62 | |
30 |
| Vienna Globa.. | 69,37 |  |
6 |
| Frankfurt | 69,0400 | |
0 |
| München | 69,04 | |
0 |
| Düsseldorf | 69,15 | |
0 |
| Lang & Schwa.. | 68,98 | |
|
| Stuttgart | 69,280 | |
|
| gettex | 69,040 | |
|
| TradeGate | 69,150 | 425 | |
| NASDAQ | 82,9700 | |
1.306.558 |
| Cboe US | 82,85 | |
89.343 |
| IEX | 82,89 | |
62.135 |
| Mexico | 1.599,31 | |
4.200 |
| London Inter.. | 81,84 | 295 |
新闻
- BioMarin sinks 32% as FDA delays its hemophilia treatment
19.08.2020 / 16:23 - TeleTrader - Nasdaq turns red as pharma stocks fall
28.04.2020 / 16:48 - TeleTrader - BioMarin Enrolls First Participant in Phase 3 Trial of Vosoritide for Treatment of Children with Achondroplasia
12.12.2016 / 14:29 - GlobeNewswire - NICE Recommends BioMarin's Vimizim® (elosulfase alfa) for the Treatment of Morquio A Syndrome in England
23.11.2015 / 16:59 - GlobeNewswire